Retrosense Therapeutics, which is working on a treatment for vision loss, has raised $6m from investors including medical diagnostics company Nerveda.

Health analytics marketplace Apervita, formerly known as Pervasive Health, secured the money from investors including General Electric.

Diabetes treatment developer Hua Medicine has completed a $25m Wuxi PharmaTech-backed round that boosted its overall funding to $75m.

Vtesse, which has spun-off from accelerator Cydan Development, secured the funding from backers including Pfizer and Lundbeck.

Colorado spins out EnteroTrack to develop gastrointestinal tract device.

Nottingham University partners Tioga to develop heartrate monitoring technology for babies.

Diagnostic testing company Adaptive has bought Celgene-backed blood cancers test developer Sequenta in a deal backed by $94m of private equity money.

Pfizer led the Roche-backed antibody developer's series C round, which boosted its overall funding to $66m.